Ligand validation:3PF1

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 3PF1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3PF1_C8E_A_505	42%	82%	0.186	0.948	0.39	0.41	-	-	2	0	76%	1
3PF1_C8E_B_506	37%	81%	0.198	0.939	0.42	0.4	-	-	4	0	76%	1
3PF1_C8E_A_508	22%	84%	0.24	0.855	0.4	0.36	-	-	5	0	100%	1
3PF1_C8E_A_507	20%	81%	0.277	0.879	0.37	0.45	-	-	7	0	100%	1
3PF1_C8E_B_520	11%	81%	0.359	0.876	0.39	0.42	-	-	1	0	100%	1
3PF1_C8E_B_530	8%	85%	0.351	0.83	0.42	0.33	-	-	15	0	100%	1
3PF1_C8E_B_535	3%	86%	0.503	0.863	0.39	0.34	-	-	7	0	100%	1
3PF1_C8E_A_509	1%	88%	0.379	0.672	0.46	0.21	-	-	3	0	43%	1
3PGS_C8E_A_438	53%	76%	0.142	0.913	0.4	0.53	-	-	3	0	95%	1
3PGR_C8E_A_430	23%	84%	0.19	0.914	0.28	0.47	-	-	0	0	43%	1
3PGU_C8E_A_449	16%	87%	0.174	0.792	0.44	0.27	-	-	0	0	71%	1
1T16_C8E_B_434	7%	27%	0.319	0.774	0.9	2.03	-	6	4	0	100%	1
2R8A_C8E_B_503	1%	31%	0.556	0.785	0.75	1.96	-	6	4	0	100%	1
2VQI_C8E_B_1638	100%	84%	0.037	0.989	0.38	0.39	-	-	0	0	100%	1
8XWO_C8E_A_402	94%	77%	0.046	0.989	0.45	0.46	-	-	2	0	76%	1
2GR7_C8E_D_1342	83%	75%	0.098	0.955	0.42	0.56	-	-	2	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	4	0	100%	1
3QRC_C8E_B_1	76%	86%	0.113	0.95	0.37	0.36	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.